We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA ACCEPTING COMMENTS ON ANDA MANUFACTURING CHANGES
FDA ACCEPTING COMMENTS ON ANDA MANUFACTURING CHANGES
March 23, 2004
Citing a lack of industry input, the FDA has reopened the comment period for a notice on time estimates for collecting information for reporting manufacturing changes on approved new drug applications (NDAs) and abbreviated new drug applications (ANDAs).